NSW Premier Mike Baird and Tasmanian Premier Will Hodgman have signed a Memorandum of Understanding (MoU), which means both states will work collaboratively on clinical trials, innovative research and the capacity for cultivating cannabis for medicinal and scientific purposes.
The MoU will combine Tasmania’s research strengths and proven track record in regulating poppy cultivation with the findings from NSW’s Centre for Medicinal Cannabis Research and Innovation.
NSW has also announced three clinical trials targeting:
- children with severe, drug-resistant epilepsy
- adults with terminal illness
- adults with chemotherapy-induced nausea and vomiting.
NSW Premier Mike Baird said it was important that decisions motivated by compassion were supported by strong science.
“There is a strong willingness and determination to learn as much as we can about the potential therapeutic benefits of cannabis so we can make decisions based on evidence, that provide safe and effective relief for patients who are suffering from a range of serious illnesses,” Mr Baird said.
Both state governments will work closely with the Australian, and other state and territory governments to achieve national regulation.